P1C-2 Liver Stiffness Measurement Using Transient Elastography in Patients with Non-Alcoholic Fatty Liver (NAFLD) and Non-Alcoholic Steatohepatitis (NASH)

Nonalcoholic fatty liver disease (NAFLD) is one of the most common causes of injury in many countries around the world. NAFLD covers a wide spectrum, ranging from simple steatosis, which is generally non progressive, to nonalcoholic steatohepatitis. There are no established noninvasive methods of evaluation for patients with NASH and until recently, liver biopsy was the unique method to quantify liver fibrosis. Liver stiffness measurement (LSM) has been proposed as non invasive tool to assess liver fibrosis in patients with hepatic chronic disease. This poster presents 3 clinical studies which demonstrate the usefulness of LSM to assess liver fibrosis in patients with histological features of NAFLD and which compared the efficiency of LSM and of two blood markers.